Accel's Europe fund now matches its US fund. That resets the ceiling on a European early-stage round

Accel said on Tuesday it had raised $3.5bn across four new funds, according to Bloomberg ^[1], and for the first time in 43 years it raised all four simultaneously ^[2]. The allocation is the news: $1.35bn for a global expansion fund, $800m for the United States, $800m for Europe and Israel, and $550m for India ^[3].

Both the US and Europe vehicles grew from $650m to $800m ^[4], a $150m step and roughly 23 percent more capital in each ^[1]. That is the ninth Europe fund the firm has raised, Sifted reported ^[5], and the European practice has been run since 2004 by Harry Nelis, a partner based in London ^[6]. The Europe and Israel fund is about 23 percent of the $3.5bn total ^[2] and about 1.45 times the size of the India fund ^[4].

For anyone raising in Europe, the practical number is not $800m. It is what the expansion fund makes reachable. Accel's $1.35bn vehicle exists so a firm with deliberately modest early-stage funds can split a large cheque between two pockets, keeping small-fund discipline while turning up to rounds those funds could not fund alone ^[10]. Stacked, that is $2.15bn of capital a European deal can in principle draw on ^[3]. Steve Loughlin, a Bay Area partner, told Bloomberg the reason plainly: "You can't really construct a fund of just those types of deals" ^[11].

The deals he means are the ones that have broken the vocabulary. Accel joined a $300m seed round in Periodic Labs last year at a $1.3bn valuation ^[13]; the trade now calls these companies neolabs, taking enormous sums at inception to fund research rather than a product ^[14]. Thinking Machines Lab, founded by former OpenAI chief technology officer Mira Murati, is an Accel company approaching a $50bn valuation after a $2bn seed ^[15]. Nelis described the cost of that environment as companies raising "more money, more quickly, earlier in their company life than ever before," while "the risk is still pretty much the same" ^[12].

Two caveats worth holding. The $800m covers Europe and Israel together, so it is not a purely European fund; Accel has said a partner's proximity to the region lets it reach Israeli founders within hours ^[9]. And the parity arrives into a concentrated market: global funding hit a record $510bn in the first half of 2026 on Crunchbase figures cited by Tech Funding News ^[16], with OpenAI and Anthropic together taking more than 40 percent of it ^[17]. In the US, megadeals took 87.5 percent of venture dollars in the second quarter ^[18]. Accel backs Anthropic ^[8], so it sits on both sides of that squeeze.

The competitive-set change is concrete. Accel has been active in European defence and AI companies ^[7] and co-led the round valuing Stockholm's Lovable at $13.3bn ^[8]. Sequoia, meanwhile, is putting $10bn behind AI and reindustrialisation ^[19].

What to watch: whether the Europe and Israel split skews toward Israel in practice, and whether European rounds start showing the expansion fund alongside the early-stage fund on the same cap table.